Lundbeck
HLUN-B.CO
#2223
Rank
โ‚น816.16 B
Marketcap
โ‚น822.62
Share price
3.74%
Change (1 day)
29.05%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2026 (TTM): โ‚น77.12 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น4.03 Billion. In 2025 the company made an earning of โ‚น71.02 Billion, an increase over its 2024 earnings that were of โ‚น52.00 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น77.12 B8.59%
2025 โ‚น71.02 B36.57%
2024 โ‚น52.00 B25.74%
2023 โ‚น41.36 B21.77%
2022 โ‚น33.96 B31.57%
2021 โ‚น25.81 B-4.61%
2020 โ‚น27.06 B-45.06%
2019 โ‚น49.26 B-34.04%
2018 โ‚น74.69 B12.83%
2017 โ‚น66.19 B93.99%
2016 โ‚น34.12 B-137.28%
2015 -โ‚น91.54 Billion-1246.24%
2014 โ‚น7.98 B-72.36%
2013 โ‚น28.89 B4.38%
2012 โ‚น27.67 B-55.18%
2011 โ‚น61.75 B5.65%
2010 โ‚น58.45 B-5.9%
2009 โ‚น62.12 B